Literature DB >> 3958496

Specificity and neutralizing capacity of antibodies elicited by a synthetic peptide of scorpion toxin.

E M Bahraoui, C Granier, J Van Rietschoten, H Rochat, M el Ayeb.   

Abstract

Polyclonal antibodies raised against a synthetic peptide (sequence 50-59) of Androctonus australis Hector toxin II can neutralize the effects of toxin II in vivo. The antigenic specificities of anti-peptide and anti-toxin antibodies were compared by competitive aqueous phase radioimmunoassay by using 125I-toxin II, chemically modified or homologous toxins, and the synthetic peptide 50-59, either free or bound to bovine serum albumin (BSA). The antipeptide and anti-toxin antibodies had a comparable high affinity for the native toxin, but anti-peptide antibodies exhibited a lower binding capacity. Anti-peptide antibodies had a higher affinity for native toxin than for the peptide 50-59 bound to BSA, used as immunogen, and were unable to recognize the free peptide. These results suggest that it is necessary to restrict the conformational freedom of the immunizing peptide in order to obtain anti-peptide antibodies with a high affinity for the toxin. The lysine residue at position 58 of toxin II, essential for toxicity, appears to be immunogenic when immunization is with peptide 50-59 bound to BSA and not with the native toxin. This residue is antigenic in the native toxin, however, as shown by the anti-peptide antibodies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958496

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Structural insights into antibody sequestering and neutralizing of Na+ channel α-type modulator from old world scorpion venom.

Authors:  Igor P Fabrichny; Grégoire Mondielli; Sandrine Conrod; Marie-France Martin-Eauclaire; Yves Bourne; Pascale Marchot
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

2.  Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein alpha-helix.

Authors:  T M Fieser; J A Tainer; H M Geysen; R A Houghten; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies.

Authors:  Y T Chen; E Stockert; Y Chen; P Garin-Chesa; W J Rettig; P van der Bruggen; T Boon; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

4.  Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man.

Authors:  M R Downham; T R Auton; A Rosul; H L Sharp; L Sjöström; A Rushton; J P Richards; T G K Mant; S M Gardiner; T Bennett; J F Glover
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

5.  Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition.

Authors:  Yu Liang; Miklos Guttman; Thaddeus M Davenport; Shiu-Lok Hu; Kelly K Lee
Journal:  Biochemistry       Date:  2016-04-04       Impact factor: 3.162

Review 6.  Innovative Immunization Strategies for Antivenom Development.

Authors:  Erick Bermúdez-Méndez; Albert Fuglsang-Madsen; Sofie Føns; Bruno Lomonte; José María Gutiérrez; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2018-11-02       Impact factor: 4.546

Review 7.  Serotherapy against Voltage-Gated Sodium Channel-Targeting αToxins from Androctonus Scorpion Venom.

Authors:  Marie-France Martin-Eauclaire; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari; Pierre E Bougis
Journal:  Toxins (Basel)       Date:  2019-01-23       Impact factor: 4.546

8.  Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids.

Authors:  Silvia A Camperi; Gerardo Acosta; Gabriela R Barredo; Lucía C Iglesias-García; Cleópatra Alves da Silva Caldeira; María C Martínez-Ceron; Silvana L Giudicessi; Osvaldo Cascone; Fernando Albericio
Journal:  Toxicon X       Date:  2020-05-05

Review 9.  Biotechnological Trends in Spider and Scorpion Antivenom Development.

Authors:  Andreas Hougaard Laustsen; Mireia Solà; Emma Christine Jappe; Saioa Oscoz; Line Præst Lauridsen; Mikael Engmark
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.